Risk of peripheral arterial thrombosis in COVID-19
- PMID: 32417015
- PMCID: PMC7203033
- DOI: 10.1016/j.jvs.2020.04.477
Risk of peripheral arterial thrombosis in COVID-19
Figures
Comment on
-
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series.J Thromb Haemost. 2020 Jul;18(7):1752-1755. doi: 10.1111/jth.14828. Epub 2020 May 11. J Thromb Haemost. 2020. PMID: 32267998 Free PMC article.
-
Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19).J Cardiovasc Pharmacol. 2020 May;75(5):359-367. doi: 10.1097/FJC.0000000000000836. J Cardiovasc Pharmacol. 2020. PMID: 32282502 Free PMC article. Review.
References
-
- Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, et al. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series [published online ahead of print April 8, 2020]. J Thromb Haemost doi: 10.1111/jth.14828. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical